Metacam Oral Suspension For Cats 15 ml
Metacam is a non-steroidal anti-inflammatory drug (NSAID) for use in cats.For alleviation of inflammation and pain in chronic musculo-skeletal disorders. Read more
Metacam is a non-steroidal anti-inflammatory drug (NSAID) for use in cats.
For alleviation of inflammation and pain in chronic musculo-skeletal disorders.
Visit www.myvetmeds.co.uk / cat / joints-mobility-cat / metacam-oral-suspension-for-cats-15-ml.htm
Product Description
About Metacam Oral Suspension For Cats 15 ml
Metacam is a non-steroidal anti-inflammatory drug (NSAID) for use in cats.
For alleviation of inflammation and pain in chronic musculo-skeletal disorders.
Please note: images are for illustration purposes only and pack sizes/strengths and new packaging styles may not be reflected in the image shown.
Directions For Use
Directions for Use
Initial treatment is a single oral dose of 0.1 mg meloxicam/kg bodyweight on the first day. Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.05 mg meloxicam/ kg bodyweight.
Particular care should be taken with regard to the accuracy of dosing. The recommended dose should not be exceeded.
Shake well before use. To be administered orally either mixed with food or directly into the mouth. The suspension can be given using the drop dispenser of the bottle for cats of any bodyweight. Alternatively and for cats with a bodyweight of at least 2 kg, the Metacam measuring syringe (provided in the package) can be used.
Dosing procedure using the drop dispenser of the bottle.
Initial dose : 6 drops/kg bodyweight.
Maintenance dose : 3 drops/kg bodyweight.
Dosing procedure using the measuring syringe.
The syringe fits onto the drop dispenser of the bottle and has a kg-bodyweight scale which corresponds to the maintenance dose. Thus for initiation of the therapy on the first day, twice the maintenance volume will be required.
A clinical response is usually seen within 7 days. Treatment should be discontinued after 14 days at the latest if no clinical improvement is apparent.
Avoid the introduction of contamination during use
Active Ingredient
Metacam Oral Suspension For Cats 15 ml ingredients
Each ml of Metacam Oral Suspension for Cats contains 0.5 mg meloxicam as active ingredient (equivalent to 0.017 mg per drop) and 1.5 mg sodium benzoate (equivalent to 0.05 mg per drop).
Side Effects
Side effects of Metacam Oral Suspension For Cats 15 ml
Do not use in pregnant or lactating animals.
Do not use in animals suffering from gastro-intestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Do not use in cats less than 6 weeks of age.
Typical adverse drug reactions of NSAIDs such as loss of appetite, vomiting, diarrhoea, faecal occult blood, apathy and renal failure have occasionally been reported. These side effects occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of renal toxicity. Response to long-term therapy should be monitored at regular intervals by a veterinary surgeon. Metacam 0.5 mg/ml Oral Suspension for Cats should not be used following parenteral injection of meloxicam or any other NSAID as appropriate dosage regimens for such follow-up treatments have not been established in cats.
Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects. Metacam must not be administered in conjunction with other NSAIDs or glucocorticosteroids.
Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such drugs should be observed for at least 24 hours before commencement of treatment. The treatment-free period, however, should take into account the pharmacokinetic properties of the products used previously. The safety of the veterinary medicinal product has not been established during pregnancy and lactation.
Meloxicam has a narrow therapeutic safety margin in cats and clinical signs of overdose may be seen at relatively small overdose levels. In case of overdose, adverse reactions as listed above are expected to be more severe and more frequent. In the case of overdosage symptomatic treatment should be initiated.
Additional Data
Metacam Oral Suspension For Cats 15 ml specification
| Specification: | Detail: |
|---|---|
| Brands: | Boehringer Ingelheim |
| Product Form: | syrup |
| External Link: | http://www.noahcompendium.co.uk/Boehringer_Ingelheim_Limited/Metacam_0_5_ACY-nbsp_ADs-mg_ml_Oral_Suspension_for_Cats/-40676.html |
| Strength/Size: | 15 ml |
